mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
3e-05 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |